Establishment of a Cisplatin-resistant Human Cervical Cancer Cell Line

Journal of Sichuan University (Medical Science)

Volumn 43, Issue 2, 2012, Pages 151-155

  Chen, Xin Lian ^a,b   Wang, He ^a,b   Zhang, Xue Mei ^a   Liu, Hong Qian ^a   Liu, Shan Ling ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Cell line; Cervical cancer; Cisplatin; Drug resistance

Indexed keywords

EID: 84860233423     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chang X, Monitto CL, Demokan S. Identification of hypermethylated genes associated with cisplatin resistance in human cancers. Cancer Res,2010,70(7) 2870-2879.
2. Kubota N, Nishio K, Takeda Y, et al. Characterization of an etoposide-resistant human ovarian cancer cell line. Cancer Chemother Pharmacol,1994,34(4) : 183-190.
3. Snow K, Judd W. Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines. Br J Cancer, 1991,63(1): 17-28.
4. Takemura Y, Kobayashi H, Gibson W, et al. The influence of drug-exposure conditions on the development of resistance to methotrexate or ZDl1694 in cultured human leukaemia cells. Int J Cancer, 1996,66(1):29-36. (Pubitemid 26122320)
5. van der Laan BF, Jansen G, Kathmann I, et al. Mechanisms of acquired resistance to methotrexate in a human squamous carcinoma cell line of the head and neck, exposed to different treatment schedules. Eur J Cancer, 1991,27(10) :1274-1278.
6. Watson MB, Lind MJ, Cawkwell L. Establishment of irrvitro models of chemotherapy resistance. Anticancer Drugs, 2007, 18 (7),749-754.
7. Zhang X, Yashiro M, Qiu H, et al. Establishment and characterization of multidrug-resistant gastric cancer cell lines. Anticancer Res,2010;30(3) :915-921.
8. Wen J, Zheng B, Hu Y, et al. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line. Oncol Rep, 2009, 22(1):65-71.
9. Rebbaa A. Targeting senescence pathways to reverse drug resistance in cancer. Cancer Lett, 2005, 219(1) :1-13. (Pubitemid 40203165)
10. Bradshaw DM, Arceci RJ. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clin Oncol,1998,16(11),3674-3690. (Pubitemid 28506783)
11. Giles GI, Sharma RP. Opoisomerase enzymes as therapeutic targets for cancer chemotherapy. Med Chem, 2005,1 ( 4 ) :383-394.
12. Mozzetti S, Ferlini C, Concolino P, et al. Class III betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin Cancer Res, 2005, 11 (1):298-305 (Pubitemid 40075808)
13. Versantvoort CH, Broxterman HJ, Bagrij T, etal. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistanceassociated protein. Br J Cancer, 1995,72(1) :82-89.
14. Cheng TC, Manorek G, Samimi G, et al. Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol, 2006,58(3):384-395. (Pubitemid 43800743)